BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35066640)

  • 1. Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP.
    Genovese M; Luti S; Pardella E; Vivoli-Vega M; Pazzagli L; Parri M; Caselli A; Cirri P; Paoli P
    Eur J Nutr; 2022 Jun; 61(4):1905-1918. PubMed ID: 35066640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
    Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
    Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
    Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
    Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
    Derkach KV; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Kuznetsova VS; Shpakov AO
    Biomed Khim; 2022 Dec; 68(6):427-436. PubMed ID: 36573409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.
    Zabolotny JM; Haj FG; Kim YB; Kim HJ; Shulman GI; Kim JK; Neel BG; Kahn BB
    J Biol Chem; 2004 Jun; 279(23):24844-51. PubMed ID: 15031294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTP1B inhibitors from Selaginella tamariscina (Beauv.) Spring and their kinetic properties and molecular docking simulation.
    Le DD; Nguyen DH; Zhao BT; Seong SH; Choi JS; Kim SK; Kim JA; Min BS; Woo MH
    Bioorg Chem; 2017 Jun; 72():273-281. PubMed ID: 28499188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
    Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
    J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance.
    Nieto-Vazquez I; Fernández-Veledo S; de Alvaro C; Rondinone CM; Valverde AM; Lorenzo M
    Diabetes; 2007 Feb; 56(2):404-13. PubMed ID: 17259385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.
    Onoda T; Li W; Higai K; Koike K
    BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(
    Derkach KV; Gureev MA; Babushkina AA; Mikhaylov VN; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Novikov AS; Krasavin M; Shpakov AO; Balova IA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-tyrosine-phosphatase 1B activation is regulated developmentally in muscle of neonatal pigs.
    Suryawan A; Davis TA
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E47-54. PubMed ID: 12388170
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Abdel-Rahman RF; Ezzat SM; Ogaly HA; Abd-Elsalam RM; Hessin AF; Fekry MI; Mansour DF; Mohamed SO
    J Nutr Sci; 2020 Jan; 9():e2. PubMed ID: 32042410
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity.
    Ramachandran C; Kennedy BP
    Curr Top Med Chem; 2003; 3(7):749-57. PubMed ID: 12678842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of protein tyrosine phosphatase 1B inhibition by theaflavanoside IV isolated from methanolic extract of tea (
    Woo HS; Im HJ; Kim JY; Lee MS; Kim DW
    Nat Prod Res; 2022 Jun; 36(12):3189-3192. PubMed ID: 34498977
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.